We found that silencing Gal-1 in MDMs prior to stimulation with EVHIV significantly reduced reactivation of latent HIV infection (Fig. 3D and E), indicating that Gal-1 secretion by EV-treated macrophages controls HIV latency reversal. The gene discussed is GAL; the disease is HIV infectious disease.